RxDoctor Payments Data

David Feldman, MD

Adult Reconstructive Orthopaedic Surgery · Englewood, NJNPI 1982667317

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $330,116 of the $335,154 with a category attached, or 98.5%. Orthopediatrics Corp. accounts for 98.5% of it on its own, with 32 other manufacturers making up the rest.

$335,154in general payments, 2019–2025

Across 140 payments — averaging $2393.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthopediatrics Corp.$330K
  • Smith+Nephew$2K
  • Seapearl East, Inc$648
  • Johnson & Johnson$477
  • Scilex Pharmaceuticals Inc.$254
  • Fidia Pharma USA Inc.$180
  • plus $1K from 27 others

What the payments were for

  • Royalty or licence$330,11698%
  • Travel & lodging$1,8621%
  • Food & beverage$2,5421%
  • Education$6350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$335,154 in reported general payments places this provider in the 85th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.

See all adult reconstructive orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$337,821
Medicare patients
464
Services billed
4,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nabumetone200$2,002
Gabapentin374$1,890
Lidocaine40$1,168
Diclofenac Sodium37$718
Pregabalin77$670
Diclofenac Sodium ErDiclofenac Sodium17$589
Meloxicam110$313
Naproxen14$126
Tramadol Hcl18$65
Oxycodone Hcl15$56

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Englewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →